Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Vancomycin Levels in Intraosseous Administration During Total Knee Arthroplasty
NCT07633418Phase 4Not yet recruiting
- Sponsor
- University of California, San Diego
- Start
- Jun 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vancomycin in Infection (2 arms), sponsored by University of California, San Diego. Primary endpoint: Serum Vancomycin Levels. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on NCT07633418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07633418.